NKH Patient Registry

NKH Patient Registry This will be a page where we will post information and updates on the New NKH Patient Registry .

Great News!!  We are excited to share that we have been approached by a NEW Metabolic Geneticist researching NKH!  He is...
02/07/2025

Great News!! We are excited to share that we have been approached by a NEW Metabolic Geneticist researching NKH! He is focusing on our older population, 18 years old and older. He is publishing a manuscript this Spring focusing on adult outcomes and prognosis. He has been vetted and has been given access to the de-identified registry!
This is another incredible milestone for all of us as this will be the First published work based on our own registry!

If your child is 18 years old or older, please take some time to go back into your registry and update anything new.

If your child is 18 years old or older, and you have not completed the patient registry, please do so as this is where this new researcher will be obtaining a lot of his data.

If you have a child of any age and have not completed the patient registry, please do so. It is critical to better treatment options and an eventual cure.

We are here to help you. If you would like a specific meeting to help you better understand the registry, why it’s important , or how to complete it, please leave your information in the comment section and we will reach out to you.

Thank you!

Join the NKH Patient Registry to provide essential data that drives research, therapies, and treatment development for Non-Ketotic Hyperglycinemia, empowering researchers and pharmaceutical companies to advance NKH solutions.

07/21/2024

It has been an incredible couple of months in our community, full of milestone announcements, all for the benefit of our children. So many talented mothers and fathers who work tirelessly around the globe for one reason: our children.

We are at a critical point in multiple research efforts at different locations. It’s time to come
together, to use our voices and our skills to make an impact larger and quicker than we can alone.

Recently NKH Crusaders held a conference in Boston and Joseph’s Goal held a virtual
conference in the UK with Nick Greene. After these conferences, Nick Greene, Joseph’s Goal, and other US Organizations held a meeting to align ways to better support the Global work being done on NKH.

Funding at this time for Nick’s work is being provided by Joseph’s Goal, grants and by other donators, but it was shared with us by Nick that his needs are beyond just funding. He has requested access to the Patient Registry and information already gathered by the US Organizations. We may be adding some additional questions for Nick to the existing patient registry questionnaire and will update more on that in the coming weeks.

So in that spirit, we are announcing today that the NKH Crusaders, along with their partners in the United States including
Brodyn’s Friends Foundation, The Nora Jane Foundation, The Lucas John Foundation, and The John Thomas Foundation, will begin a more collaborative working relationship with Joseph’s Goal in the UK. We’ve made this decision to help create an environment of transparency and trust.

It’s important to recognize, that we have always worked together and supported each other, and we are formalizing that now so that there is no confusion. We are all working together towards a common mission of curing NKH and finding better treatment options as soon as possible for our
children.

Our individual organizations will still be supporting the researchers that each organization chooses to support. However, we will be working together to make sure that the needs of our community around the globe, regarding any future clinical trials are met.

Our first two projects together in 2024 will be based on the feedback we received from the FDA and suggestions from Nick Greene. The FDA asked very specific questions regarding the barriers that we see as a community - getting to the clinical trials, financial and travel barriers etc. Please be looking for more information on that soon.

We also plan to collaborate with the researchers and each other to continue to build on an already robust patient registry. We are asking families who have not completed the registry to do so and we will be working with Joseph’s Goal and other US organizations to reach families that exist but have not yet been identified due to social differences. The information in this registry is
needed not only by US researchers but also Nick Greene.

We are excited about what the remainder of 2024 will bring for all of us.

During our recent meeting, Nick's budget needs and funding were discussed. To keep in the spirit of transparency, Joseph's Goal is to share how they have been financially supporting Nick’s work.

Below is a statement from Joseph’s Goal:

Dr Nick Greene and his research team at UCL are making huge strides in trying to solve the puzzle of NKH.

The majority of Nick’s research grants are specifically tied to fixed targets, but funding from Joseph’s Goal has no such restrictions - and therefore allows Nick to explore other areas of NKH. This has accelerated the rate at which Nick has progressed his research by years.

Joseph’s Goal has been funding Nick for eight years. We have already committed £955,000 ($1,212,000) to UCL.

Before funding Nick Greene and his research, Joseph’s Goal also committed £205,598 ($312,753) to Dr. Johan van Hove and his own NKH research studies.

Our funding, combined with all of the work that the US organizations have done can aid Nick Greene in moving research forward stronger and faster.

It is abundantly clear that we need each other. The researchers need us. Let’s truly come together and make the dream of a cure a reality.

Alone, We are Rare, Together we are Strong.

NKH Survey for USA Families only at this time due to funding a site locations.   We are exploring ways if the grant is a...
07/16/2024

NKH Survey for USA Families only at this time due to funding a site locations. We are exploring ways if the grant is approved to open internationally.

IN-TIME Consortium Survey:

We are excited to share that the NKH Community has been asked to participate in the IN-Time Consortium; (Infantile Treatable Inherited Metabolic Epilepsy.) This proposed grant will impact the 4 disorders below. We are thrilled that Dr. Curtis Coughlin, who has worked with Dr. Van Hove for over a decade, felt that NKH fit the profile needed for this potential grant. The grant would provide funding for 5 years of 1 million dollars to build a natural history study, research newborn screening options, and help us to be ready for Clinical Trials. Results of the grant will be announced in the 2nd quarter of 2025. To prepare, we are collecting the data on this survey to gather information from families on their willingness and ability to participate in this 3 to 5 year trial. We expect 25 participants to be selected from each rare disease. This grant is due on August 1, 2024 so we ask you to fill out this survey by Thursday July 26, 2024.

The Rare Disease Clinical Research Network (RDCRN) is a National Institutes of Health (NIH)-funded research network dedicated to achieving faster diagnoses and better treatment options for individuals living with rare diseases. Several experts in the field are collaborating on a grant proposal to submit to the RDCRN entitled, IN-TIME (Infantile Treatable Inherited Metabolic Epilepsies) Consortium to advance our understanding of inherited metabolic epilepsies, develop diagnostic approaches, evaluate treatment methods, and share information. (https://www.rarediseasesnetwork.org/)

This grant will combine the following 4 rare disorders:
1. B6 responsive seizures
PLPBP
PNPO
PDE-ALDH7A1
2. Cerebral Creatine Deficiency Syndromes (CCDS)
AGAT
CTD
GAMT
3. NonKetotic Hyperglycinemia (NKH)
4. Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)

This survey aims to gather data on the interest within our specific communities and identify any barriers that may prevent your participation. Completion of this survey does not guarantee enrollment into the study.

If you have more than one child impacted by the disease, please fill out the survey for each child.

Please use this link to access the survey: https://forms.gle/46tTp4wQLYxoK7VT6

This grant is being overseen by the following Scientific Leads: Dr. Curtis Coughlin, Dr. Phillip Pearl, Dr. Nicola Longo, Dr. Marzia Pasquali, Dr. Johan Van Hove, Dr. Sarah Elsea, Dr. Melissa Haendel.

Please reach out to Kristin Archibald, Heidi Leslie or Amanda Almany with any questions.

The Rare Disease Clinical Research Network (RDCRN) is a National Institutes of Health (NIH)-funded research network dedicated to achieving faster diagnoses and better treatment options for individuals living with rare diseases. Several experts in the field are collaborating on a grant proposal to su...

04/22/2024

Join us Wednesday night to learn how we can work together to make an immediate impact! Drop your email in the comments to receive the zoom invite

Address

Boston, MA

Alerts

Be the first to know and let us send you an email when NKH Patient Registry posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share